Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

318 public trials 57 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Active, Not Recruiting

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

NCT06353087

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +10 more
Locations
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • Chang Gung Memorial Hospital at Kaohsiung Kaohsiung City, Taiwan
  • Taipei Medical University - Shuang Ho Hospital New Taipei City, Taiwan
  • NTUH Taipei, Taiwan
View Trial Details
Active, Not Recruiting

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

NCT03162536

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mayo Clinic Hospital ( Site 0140) Scottsdale, Arizona, United States
  • UCLA Hematology & Oncology ( Site 0017) Los Angeles, California, United States
  • Colorado Blood Cancer Institute ( Site 0225) Denver, Colorado, United States
  • University of Michigan ( Site 0018) Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

NCT05186753

Conditions
BMM, Bone Marrow Mastocytosis, Hematologic Diseases, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • One of a Kind Clinical Research Center Scottsdale, Arizona, United States
  • Modena Allergy and Asthma Clinical La Jolla, California, United States
View all 57 locations
View Trial Details
Active, Not Recruiting

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

NCT05018585

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Mary and Dick Allen Diabetes Center at Hoag Hospital Newport Beach, California, United States
  • Stanford University School of Medicine Center for Academic Medicine Palo Alto, California, United States
  • UCSD/ Rady Children's Hospital San Diego, California, United States
  • University of Colorado Anschutz Medical Campus, Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States
View all 60 locations
View Trial Details

Related conditions